Outcome | PFS | ||
---|---|---|---|
HR | 95%CI | P value | |
KLRG1 expression level (High vs. Low) | 0.139 | 0.029–0.668 | 0.014 |
Drug (Nivolumab vs. Pembrolizumab) | 8.781 | 1.332–57.878 | 0.024 |
Biopsy (Archival vs. Baseline) | 0.248 | 0.094–1.842 | 0.248 |
Smoking history (Current smoker & Former smoker vs. Never smoker) | 2.930 | 0.311–27.575 | 0.347 |
Gender (Male vs. Female) | 0.263 | 0.048–1.447 | 0.125 |
Age (< 58 vs. ≥58) | 0.417 | 0.110–1.579 | 0.198 |
ECOG (0 vs. 1) | 0.480 | 0.093–2.480 | 0.381 |